Genomic-Guided Adjuvant Therapy in Early-stage Endometrial Cancer: a Review
Current data support the incorporation of tumor genomic analysis into routine clinical decision-making as an important step toward precision-based care in endometrial cancer, and suggest that molecular profiling may better identify patients who would benefit from treatment intensification or de-escalation compared with...